Literature DB >> 19427900

Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.

Karthikeyan Mythreye1, Gerard C Blobe.   

Abstract

Signaling co-receptors are diverse, multifunctional components of most major signaling pathways, with roles in mediating and regulating signaling in both physiological and pathophysiological circumstances. Many of these signaling co-receptors, including CD44, glypicans, neuropilins, syndecans and TssRIII/betaglycan are also proteoglycans. Like other co-receptors, these proteoglycan signaling co-receptors can bind multiple ligands, promoting the formation of receptor signaling complexes and regulating signaling at the cell surface. The proteoglycan signaling co-receptors can also function as structural molecules to regulate adhesion, cell migration, morphogenesis and differentiation. Through a balance of these signaling and structural roles, proteoglycan signaling co-receptors can have either tumor promoting or tumor suppressing functions. Defining the role and mechanism of action of these proteoglycan signaling co-receptors should enable more effective targeting of these co-receptors and their respective pathways for the treatment of human disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427900      PMCID: PMC2735586          DOI: 10.1016/j.cellsig.2009.05.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  155 in total

Review 1.  Protein ectodomain shedding.

Authors:  Joaquín Arribas; Aldo Borroto
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  Membrane lipid organization is critical for human neutrophil polarization.

Authors:  Lynda M Pierini; Robert J Eddy; Michele Fuortes; Stephanie Seveau; Carlo Casulo; Frederick R Maxfield
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

Review 3.  CD44: from adhesion molecules to signalling regulators.

Authors:  Helmut Ponta; Larry Sherman; Peter A Herrlich
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

4.  Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.

Authors:  M Kato; S Saunders; H Nguyen; M Bernfield
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

5.  Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior.

Authors:  R D Sanderson; J E Turnbull; J T Gallagher; A D Lander
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

6.  Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells.

Authors:  M J Stanley; B F Liebersbach; W Liu; D J Anhalt; R D Sanderson
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

7.  Expression of syndecan-1 inhibits cell invasion into type I collagen.

Authors:  B F Liebersbach; R D Sanderson
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

8.  Inhibin is an antagonist of bone morphogenetic protein signaling.

Authors:  Ezra Wiater; Wylie Vale
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

Review 9.  Function of the syndecans--a family of cell surface proteoglycans.

Authors:  K Elenius; M Jalkanen
Journal:  J Cell Sci       Date:  1994-11       Impact factor: 5.285

10.  Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.

Authors:  V B Lokeshwar; N Fregien; L Y Bourguignon
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

View more
  49 in total

Review 1.  Heparan sulfate signaling in cancer.

Authors:  Erik H Knelson; Jasmine C Nee; Gerard C Blobe
Journal:  Trends Biochem Sci       Date:  2014-04-19       Impact factor: 13.807

2.  The Tiam1 PDZ domain couples to Syndecan1 and promotes cell-matrix adhesion.

Authors:  Tyson R Shepherd; Suzi M Klaus; Xu Liu; S Ramaswamy; Kris A DeMali; Ernesto J Fuentes
Journal:  J Mol Biol       Date:  2010-03-31       Impact factor: 5.469

3.  Heparanase Modulates Shh and Wnt3a Signaling in Human Medulloblastoma Cells.

Authors:  Lon D Ridgway; Michael D Wetzel; Dario Marchetti
Journal:  Exp Ther Med       Date:  2011-03-01       Impact factor: 2.447

Review 4.  Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.

Authors:  Atsuko Yoneda; Maria E Lendorf; John R Couchman; Hinke A B Multhaupt
Journal:  J Histochem Cytochem       Date:  2012-01       Impact factor: 2.479

Review 5.  Auxiliary and autonomous proteoglycan signaling networks.

Authors:  Arye Elfenbein; Michael Simons
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

6.  BMP-2 and TGFβ2 shared pathways regulate endocardial cell transformation.

Authors:  Todd A Townsend; Jamille Y Robinson; Christopher R Deig; Cynthia R Hill; Andrew Misfeldt; Gerard C Blobe; Joey V Barnett
Journal:  Cells Tissues Organs       Date:  2011-01-07       Impact factor: 2.481

7.  Efficient secretion of biologically active Chondroitinase ABC from mammalian cells in the absence of an N-terminal signal peptide.

Authors:  Michael Klüppel
Journal:  Mol Cell Biochem       Date:  2011-01-07       Impact factor: 3.396

8.  Endocan, a novel inflammatory marker, is upregulated in human chondrocytes stimulated with IL-1 beta.

Authors:  Michele Scuruchi; Angela D'Ascola; Angela Avenoso; Giuseppe Mandraffino; Salvatore Campo; Giuseppe M Campo
Journal:  Mol Cell Biochem       Date:  2021-01-05       Impact factor: 3.396

9.  Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.

Authors:  Erik H Knelson; Angela L Gaviglio; Jasmine C Nee; Mark D Starr; Andrew B Nixon; Stephen G Marcus; Gerard C Blobe
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

10.  A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx.

Authors:  Geerte L Van Sluis; Max Nieuwdorp; Pieter W Kamphuisen; Johan van der Vlag; Cornelis J F Van Noorden; C Arnold Spek
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.